UM Ventures is a joint initiative of the University of Maryland, Baltimore and University of Maryland, College Park to commercialize technologies and expand industry collaboration.
Compound created at University of Maryland now in clinical trials
Forbes Names University of Maryland, College Park One of American’s Top 50 Most Entrepreneurial Universities
Harpoon Has Raised More Than $300,000 in Competitive Grants and Award Funding in Less Than a Year
Data storage is one of the most popular applications of cloud computing.
College Park, MD – Diagnostic anSERS has introduced a groundbreaking SERS sensor that enables trace chemical detection for only a few dollars per test, a sensor that is poised to bring SERS into the mainstream...
UM Ventures is organized to move research outcomes into products and services, tools and diagnostics that will benefit society.
Novel small molecule Lipid II inhibitors as broad-spectrum antibacterial agents. Search “ED-2010-066 and ED-2012-088”
Sign up to receive current new technology announcements and other UM Ventures news.